Fortive R&D increased by 0.8% to $66.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.9%, from $64.00M to $66.50M. Over 3 years (FY 2021 to FY 2025), R&D shows a downward trend with a -5.3% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $87.80M | $87.80M | $93.00M | $99.10M | $100.10M | $101.10M | $101.20M | $100.10M | $100.10M | $98.40M | $104.10M | $101.10M | $62.00M | $65.20M | $64.00M | $109.20M | $62.00M | $66.00M | $66.50M |
| QoQ Change | — | +0.0% | +5.9% | +6.6% | +1.0% | +1.0% | +0.1% | -1.1% | +0.0% | -1.7% | +5.8% | -2.9% | -38.7% | +5.2% | -1.8% | +70.6% | -43.2% | +6.5% | +0.8% |
| YoY Change | — | — | — | — | +14.0% | +15.1% | +8.8% | +1.0% | +0.0% | -2.7% | +4.0% | +1.0% | -37.0% | — | -38.5% | +8.0% | +0.0% | +1.2% | +3.9% |
Range$62.00M – $109.20M
CAGR-6.0%
Avg YoY Growth-1.5%
Median YoY Growth+1.1%
Current Streak2 quarters growth
R&D at Other Companies
Frequently Asked Questions
- What is Fortive's r&d?
- Fortive (FTV) reported r&d of $66.50M in Q1 2026.
- How has Fortive's r&d changed year-over-year?
- Fortive's r&d increased by 3.9% year-over-year, from $64.00M to $66.50M.
- What is the long-term trend for Fortive's r&d?
- Over 3 years (2021 to 2025), Fortive's r&d has grown at a -5.3% compound annual growth rate (CAGR), from $354.80M to $301.20M.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.